Impacts of echocardiography-defined pulmonary hypertension on clinical outcome in patients with multiple myeloma

被引：0

作者：

Bae, S. A. ^{[1
]}

Yoon, H. J. ^{[1
]}

Kim, K. H. ^{[1
]}

Kim, H. Y. ^{[1
]}

Park, H. J. ^{[1
]}

Cho, J. Y. ^{[1
]}

Jeong, M. H. ^{[1
]}

Park, J. C. ^{[1
]}

机构：

[1] Chonnam Natl Univ, Sch Med, Dept Cardiovasc Med, Gwangju, South Korea

来源：

EUROPEAN HEART JOURNAL | 2019年 / 40卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P671

引用

页码：279 / 279

页数：1

共 50 条

[31] Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome
Trakada, Georgia
Kastritis, Efstathios
Gavriatopoulou, Maria
Velentza, Lemonia
Fotiou, Despina
Ziogas, Dimitrios C.
Panagiotidis, Ioannis
Eleutherakis-Papaiakovou, Evangelos
Roussou, Maria
Migkou, Magdalini
Kanellias, Nikolaos
Ntanasis-Stathopoulos, Ioannis
Kallianos, Anastasios
Terpos, Evangelos
Dimopoulos, Meletios A.
ANNALS OF HEMATOLOGY, 2019, 98 (06) : 1427 - 1434
[32] The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIs
Franssen, L. E.
van de Donk, N. W. C. J.
Emmelot, M. E.
Roeven, M. W. H.
Schaap, N.
Dolstra, H.
Hobo, W.
Lokhorst, H. M.
Mutis, T.
BONE MARROW TRANSPLANTATION, 2015, 50 (06) : 822 - 828
[33] The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIs
L E Franssen
N W C J van de Donk
M E Emmelot
M W H Roeven
N Schaap
H Dolstra
W Hobo
H M Lokhorst
T Mutis
Bone Marrow Transplantation, 2015, 50 : 822 - 828
[34] Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide
Phoebe A. Huang
Shaunna L. Beedie
Cindy H. Chau
David J. Venzon
Sheryl Gere
Dickran Kazandjian
Neha Korde
Sham Mailankody
Ola Landgren
William D. Figg
Scientific Reports, 9
[35] Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma
Badar, Talha
Srour, Samer
Bashir, Qaiser
Shah, Nina
Al-Atrash, Gheath
Hosing, Chitra
Popat, Uday
Nieto, Yago
Orlowski, Robert Z.
Champlin, Richard
Qazilbash, Muzaffar H.
EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (03) : 263 - 268
[36] Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide
Huang, Phoebe A.
Beedie, Shaunna L.
Chau, Cindy H.
Venzon, David J.
Gere, Sheryl
Kazandjian, Dickran
Korde, Neha
Mailankody, Sham
Landgren, Ola
Figg, William D.
SCIENTIFIC REPORTS, 2019, 9 (1)
[37] CD200 genotype is associated with clinical outcome of patients with multiple myeloma
Gonzalez-Montes, Yolanda
Osca-Gelis, Gemma
Rodriguez-Romanos, Rocio
Villavicencio, Alicia
Gonzalez-Bartulos, Marta
Llopis, Francesca
Clapes, Victoria
Oriol, Albert
Sureda, Anna
Escoda, Lourdes
Sarra, Josep
Garzo, Ana
Lloveras, Natalia
Gomez, Beatriz
Granada, Isabel
Gallardo, David
FRONTIERS IN IMMUNOLOGY, 2024, 15
[38] Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myeloma
Richardson, PGG
Barlogie, B
Berenson, J
Singhal, S
Jagannath, S
Irwin, D
Rajkumar, SV
Hideshima, T
Xiao, H
Esseltine, D
Schenkein, D
Anderson, KC
BLOOD, 2005, 106 (09) : 2977 - 2981
[39] Impact of systemic hypertension on clinical outcome of patients with idiopathic pulmonary arterial hypertension: a retrospective study
Cheng, Xiao-Ling
Liu, Zhi-Hong
Gu, Qing
Ni, Xin-Hai
Zhao, Zhi-Hui
Luo, Qin
He, Jian-Guo
Xiong, Chang-Ming
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 12091 - 12096
[40] Long Intergenic Non-Coding RNAs (lincRNA) Impacts Biology and Clinical Outcome in Multiple Myeloma
Samur, Mehmet Kemal
Rashid, Naim
Cleynen, Alice
Fulciniti, Mariateresa
Sperling, Adam
Minvielle, Stephane
Anderson, Kenneth C.
Parmigiani, Giovanni
Avet-Loiseau, Herve
Munshi, Nikhil C.
BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →